|Articles|March 18, 2021
Application Note: Hyaluronic Acid MW and Conformation by SEC-MALS-IV
Author(s)Wyatt Technology
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
4
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
5